The main goal in STEMI is to restore blood flow to reduce myocardial injury, Mehran explained. The novel glycoprotein ...

Zalunfiban, a prehospital platelet inhibitor given by injection at the point of first medical contact for suspected STEMI, ...

Amgen's Repatha lowered first heart attacks and strokes by 36% in a major trial, suggesting PCSK9 drugs may prevent acute ...

Heart attacks remain a significant health concern in the United States. According to the Centers for Disease Control and Prevention (CDC), approximately 805,000 Americans experience a heart attack ...

With new phase 3 data backing the ability of its emergency use zalunfiban to fend off further heart damage, CeleCor ...

The single dose treatment helped patients lower “bad” cholesterol and triglyerides, both linked to heart disease ...

The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved the first-ever IV iron replacement therapy to improve exercise capacity in adults with ...

Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an ...